Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T20:43:03.592Z Has data issue: false hasContentIssue false

The Role of Intention-to-Treat Analyses in Randomized Trials

Published online by Cambridge University Press:  02 January 2015

Joshua C. Herigon
Affiliation:
Children's Mercy Hospital and Clinics, Section of Infectious Diseases, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri
Jason G. Newland*
Affiliation:
Children's Mercy Hospital and Clinics, Section of Infectious Diseases, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri Department of Pediatrics, Section of Infectious Diseases, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri
*
Children's Mercy Hospital and Clinics, Section of Infectious Diseases, 2401 Gillham Road, Kansas City, MO (jnewland1@cmh.edu)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

References

1.Fritz, SA, Camins, BC, Eisenstein, KA, et al. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol 2011;32:872880.Google Scholar
2.Abraha, I, Montedori, A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ 2010;340:c2697.Google Scholar